Product portfolio demonstrates Company’s
investment in innovative technology, world-class product
development and production
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to continue the
roll out of its innovative portfolio of recreational adult use
cannabis products including vape pens and cannabis-infused
chocolate.
Edison Vape Pens Powered by Feather
Organigram has sent its first shipments of its Edison vape pens
powered by Feather technology to jurisdictions across Canada from
the Company’s Moncton production campus.
Organigram, for its Edison Cannabis Co. brand, has an exclusive
agreement in Canada with Feather Company Ltd. (“Feather”), a
cannabis innovator committed to the production of premium-quality
products that enhance the cannabis experience for consumers. Edison
vape pens rely on Feather’s innovative technology and pen
construction.
The well-crafted, inhalation-activated pens are designed to
offer adult consumers a simple, intuitive user experience. The
ready-to-use vape pens combine sophisticated design, cannabis
distillate and curated terpene blends, representative of Edison’s
star strains’ iconic aroma profiles.
These include:
● Rio Bravo – With terpinolene, caryophyllene, myrcene
and pinene terpenes, this formulation captures the flavour of
Edison’s Rio Bravo flower.
● Lola Montes – This precise blend of dominant terpenes
including limonene, caryophyllene, myrcene and linalool celebrates
the flavour profile of Edison’s Lola Montes flower.
● La Strada – Edison’s La Strada strain is brought to
life through this formulation with terpenes including myrcene,
alpha and beta pinene, caryophyllene, and humulene.
“We’re pleased to release this advanced device, which will offer
consumers a new consumption option,” says Greg Engel, CEO,
Organigram. “The sleek, subtle, compact design and intuitive
function of the Edison powered by Feather device creates a distinct
offering, especially when combined with our signature Edison
formulations; a breadth of variety will help strengthen the appeal
of the regulated market and we’re proud to contribute this line of
products to the Canadian retail market.”
The Edison vape pen is constructed with a ceramic atomizer,
internal stainless-steel components and borosilicate glass. No
vitamin E acetate, propelyne glycol, vegetable glycerin or
medium-chain triglyceride (MCT) are used in the formulation of the
products; cannabinoids are extracted using C0₂.
The Edison pens are ready-to-use upon inhalation, with no time
required to heat internal components, and do not require any
chargers, additional cartridges, or separate batteries. Pens are
available in 0.3-gram units, with a target potency of 80% THC (800
mg/g), though potency may slightly exceed or be less than
target.
“As Canadians, seeing Feather launch in our backyard after the
demonstrable success we’ve had in Colorado, is a proud moment for
our entire team,” says Patrick Lehoux, CEO, Feather Company Ltd.
“Our goal has always been simple, to design intuitive products that
seamlessly fit into our customers lives and elevate their everyday
moments.”
The Company’s next-generation product portfolio includes
high-quality infused chocolate and a dissolvable powdered beverage
product, created using nanotechnology and providing a discreet and
customizable experience for the consumer. First shipments of
chocolate and dissolvable powder products are expected in calendar
Q1 and Q2 of 2020, respectively. The Feather launch follows the
release of the Company’s first 2.0 offering, the Trailblazer Torch,
which launched in Canada on December 17, 2019.
Edison Bytes
Following a $15 million investment in a high-speed,
high-capacity, fully automated production line, the first run of
Organigram’s cannabis-infused chocolate offering has also shipped
to retailers across Canada.
Edison Bytes, the Company’s premium cannabis-infused chocolate
truffles available in both milk and dark chocolate formulations,
are the first of Organigram’s chocolate products to be available to
Canadian adult consumers. Products will be available as single
chocolates containing 10 mg of cannabis each and sets of two
truffles containing 5 mg each.
The chocolate making process is the product of collaboration
between Organigram’s engineering and quality assurance teams.
Organigram’s teams have dedicated efforts to producing a
homogeneous product, reliably and consistently distributing defined
doses of cannabis throughout the ganache.
“Our team and partners have been identified for their own global
expertise and unwavering commitment to quality,” says Engel.
“Everyone involved in the conception, development and delivery of
this line values creativity, curiosity and leadership. We are all
committed to applying our experience and expertise to the
development of a portfolio of novel products that delight our
customers.”
About Feather Company Ltd.
Feather Company Ltd. is a lifestyle design brand. We believe
that good design combined with quality cannabis makes for great
intuitive experiences. Our mission is simple, we make great
products that elevate the everyday, one person and one moment at a
time. Feather is a Canadian-based, global company, headquartered in
Sudbury, with offices in Toronto, Ottawa and Denver, Colorado. You
can find Feather products in dispensaries throughout Canada,
Colorado and soon in California and the United Kingdom.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that could change anticipated timelines for product
launches and product composition in accordance with regulatory
requirements; including risks as disclosed in the Company’s most
recent annual information form, management’s discussion and
analysis and other Company documents filed from time to time on
SEDAR (see www.sedar.com) and filed or furnished to the Securities
and Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200220005427/en/
For Investor Relations enquiries, please contact: Amy
Schwalm Vice President, Investor Relations
Amy.Schwalm@organigram.ca (416) 704-9057
Patrick Lehoux Founder and CEO pat@feather.com (705)
562-6647
For Media enquiries, please contact: Ray Gracewood Senior
Vice President, Marketing and Communications
ray.gracewood@organigram.ca (506) 645-1653
Dominic Choballe Chief Creative Officer dom@feather.com (613)
261-9417
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2024 to May 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From May 2023 to May 2024